Skip to main content
. 2021 Feb 15;11(6):1555–1567. doi: 10.1016/j.apsb.2021.02.011

Table 1.

The molecule name (MolName), CAS, molecule weight (MW, g/mol), calculated binding energies (ΔGADV, kcal/mol), and BLI binding kinetics (KD, kon, kdis, and R2) of compounds selected from primary in vitro binding screen.

No. Mol. name CAS MW ΔGADV KD (μmol/L) kon (L/(mol·s)) kdis (1/s) Full R2
1 Pazopanib 444731-52-6 437.5 −9.2 N.D.a N.D. N.D. N.D.
11 Verbascoside 61276-17-3 624.6 −8.3 0.84 ± 0.85 108 9.05×10−5 98%
19 Zafirlukast 107753-78-6 575.7 −9.5 >1000 8.43 4.99 87%
21 Paliperidone 144598-75-4 426.5 −8.6 N.D. N.D. N.D. N.D.
25 Pictilisib 957054-30-7 513.6 −8.7 N.D. N.D. N.D. N.D.
27 steviolbioside 41093-60-1 642.7 −9.4 N.D. N.D. N.D. N.D.
34 COH29 1190932-38-7 420.4 −8.5 >1000 8.10 0.189 87%
35 Oleanonic Acid 17990-42-0 454.7 −9.6 171.00 ± 35.90 98.4 1.68×10−2 84%
36 Forsythoside A 79916-77-1 624.6 −8.7 1.16 ± 0.44 137 1.59×10−4 99%
37 Corilagin 23094-69-1 634.5 −8.9 0.54 ± 0.01 496 2.68×10−4 97%
38 Ligustroflavone 260413-62-5 724.7 −10.1 N.D. N.D. N.D. N.D.
40 Ledipasviracetone 1441674-54-9 947.1 −9.5 N.D. N.D. N.D. N.D.
44 Narirutin 14259-46-2 580.5 −9.0 N.D. N.D. N.D. N.D.
45 MK-3903 1219737-12-8 454.9 −8.9 220.00 ± 19.40 302 6.65×10−2 96%
47 T-5224 530141-72-1 517.5 −8.6 38.70 ± 1.63 200 7.74×10−3 98%
50 AMG-900 945595-80-2 503.6 −9.1 N.D. N.D. N.D. N.D.
a

N.D. = not detected.